Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) EPS (Basic) (2024 - 2026)

Kestra Medical Technologies (KMTS) reported EPS (Basic) of -$0.61 for Q1 2026, up 51.2% year-over-year from -$0.4 in Q1 2025, and up 4.69% on a QoQ basis from -$0.64 in Q4 2025.

Kestra Medical Technologies (KMTS) has 3 years of EPS (Basic) data on file, last reported at -$0.61 in Q1 2026.

  • Quarterly EPS (Basic) rose 51.2% year-over-year to -$0.61 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was -$3.32 (up 30.54% YoY) and the FY2025 annual result came in at -$5.13, down 1.18% from the prior year.
  • EPS (Basic) rose to -$0.61 in Q1 2026 per KMTS's latest filing, from -$0.64 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.5 in Q3 2025 and bottomed at -$1.57 in Q2 2025.
  • The 3-year median for EPS (Basic) is -$1.18 (2024), against an average of -$1.03.
  • Peak annual rise in EPS (Basic) reached 55.36% in 2025, while the deepest fall reached 28.69% in 2025.
  • Tracing KMTS's EPS (Basic) over 3 years: stood at -$1.19 in 2024, then soared by 46.22% to -$0.64 in 2025, then rose by 4.69% to -$0.61 in 2026.
  • Per Business Quant, the three latest KMTS EPS (Basic) figures stand at -$0.61 (Q1 2026), -$0.64 (Q4 2025), and -$0.5 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.31
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -0.13
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 2.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.93
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.07
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.58
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -0.03
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.13
10 Kestra Medical Technologies 1.13 Bn 840.05 Mn 12.91 Mn -0.61

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 -0.61
Oct 31, 2025 -0.64
Jul 31, 2025 -0.50
Apr 30, 2025 -1.57
Jan 31, 2025 -1.25
Oct 31, 2024 -1.19
Jul 31, 2024 -1.12
Apr 30, 2024 -1.22
Jan 31, 2024 -1.18